HEALTH INSURANCE COST OF DIABETES MELLITUS IN HUNGARY- A COST OF ILLNESS STUDY
Author(s)
Gresz M1, Varga S2, Kriszbacher I2, Sebestyén A3, Boncz I21National Health Insurance Fund Administration, Budapest, Hungary, 2University of Pécs, Pécs, Hungary, 3National Health Insurance Fund Administration, Pécs, Hungary
OBJECTIVES: Diabetes is one of that chronic diseases in which the increase of the costs cause financial problems for the National Health Insurance Fund in Hungary. Aim of the study is the examination of it in a 5-year period from 2003 to 2008. METHODS: The number of diabetic patients, the type of treatment services, the financial support and the costs were analyzed. Data were derived from the National Health Insurance Fund Administration. RESULTS: Measuring by the medical ID, the numbers of patient increased by 34% during 5 years. The numbers of case increased in the out-patient services by 14% (from 213,790 to 243,960). The numbers of the hospital treatment day decreased by 5% (3,342,857; 3,168,263) The day off work due to sickness and the cost of it increased by 345% (from 8,275€ to 36,860€). While financial support of devices for the measurement of blood sugar increased by 93% €4,900 to €9,400 and support of insulin treatment increased 111%, than the increase of the number of insulin treated patients was only 46%, 91,920 (2003) and 134,617 (2008). Similarities were seen in numbers (40%) and in costs (94%) in the non-insulin treated patients from 195,662 to 274,886 and from €7,900 to €15,300. The total change in financial support was 72%. CONCLUSIONS: Increase in the number of diabetic patients was seen during this 5-year period. The increase of the number in out-patient services was higher than in in-patient services. The decrease in numbers of hospital bed could explain it. The economic crisis could cause the growing in the numbers of day off work. The increase in the medical financial support compared to the number of patients had to be mentioned, because it could be caused by enhancement in the administration of the innovative medical products. Basic strategy should be found against health cost explosion.
Conference/Value in Health Info
2010-11, ISPOR Europe 2010, Prague, Czech Republic
Value in Health, Vol. 13, No. 7 (November 2010)
Code
PDB28
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Diabetes/Endocrine/Metabolic Disorders